Features include non-invasive Glucose Monitoring, ECG, Blood Pressure, Heart Rate, Oxygenation, Respiratory Rate, Body Temperature and Sleep Tracking
Deep-tech AI technology company, AITIS, is pleased today to announce the launch of mymonX, the ultimate AI health monitoring solution that combines a smart wearable and an app to stay on top of health and well-being. The smart wearable is available on the mymonX website for £249 with full access to all the features of the mymonX app for £9.99/month. This includes a monthly personalised doctor-reviewed health report, that will highlight any changes to vital trends.
mymonX understand that health is more than just the absence of disease. It's about optimizing physical, mental, and emotional well-being which is why it has developed a wearable that monitors key health indicators in real-time, using the sensor-based data with other data items to drive AI models that are able to identify other vitals, providing users with personalised insights to improve their overall health and wellness.
mymonX is the ultimate AI health monitoring solution, revolutionising wearable technology, tracking glucose, heart health, blood pressure, heart rate, oxygenation, respiratory rate, body temperature, sleep and activity. It is this understanding of the user’s health which allows them to see what a huge difference small daily changes could make to their overall quality of life.
Through the mymonX app, detailed insights and analytics about health metrics are provided, which, over time allows users to track their progress, set goals and reminders. This data can even be shared with loved ones and caregivers so that they can monitor the health of their loved ones.
Non-Invasive Glucose Monitoring
mymonX can determine glucose measurements non-invasively, without the need for blood pricks or continuous glucose monitors through AI innovation. Its AI-based non-invasive glucose monitoring (mmol/L) can help people better manage their blood sugar levels. Having high blood glucose (or sugar) levels can lead to serious health complications. By tracking their glucose levels throughout the day, people can identify trends, and make lifestyle adjustments to their diet and physical activity to aim to keep their levels within a healthy range. MymonX’s measurements are within the ISO 15197 guidelines and all their values are within Zone A and B using the Clarke Error Grid Analysis (widely used to evaluate the accuracy of blood glucose monitors).
The on-demand ECG measures the electrical activity of the heart to assess the health of the heart and diagnose a variety of conditions through AI innovation. The AI-based ECG report on mymonX alerts to detect potential problems with the heart's rhythm and structure, such as a heart attack, arrhythmias, and other abnormalities.
In addition to, Blood Pressure, Heart Rate, Oxygenation and Respiratory Rate.
mymonX also monitors body temperature, sleep, and includes a step count to monitor exercise throughout the day.
The mymonX smart wearable is sleek and stylish, with a comfortable fit that's perfect for all-day wear. It's available in a range of colours and styles to suit most preferences, and features a high-resolution touchscreen display that's easy to read and navigate. The interface is also extremely intuitive and easy to use, making it simple to track health metrics and stay on top of health goals. Additionally, with a battery life of up to a week from 3 hours of charging and IP68 Water resistance, the mymonX never needs to leave the wearer’s arm.
Sylvia Smit, CEO of AITIS, commented, “Having been involved in creating AI healthcare solutions for a number of years, focusing on AI-diagnostics, we also moved into prevention after having seen first- hand when health begins to fail and the impact of chronic diseases like diabetes, heart and lung conditions. Globally, over a third of the population has a chronic disease. This means that two-thirds do not and we want to provide them with the knowledge of how healthy they are and empower them to take control to remain healthy. Unlike other health wearables, we also provide monthly personalised doctor-reviewed health reports to help interpret what vitals means from a doctor’s perspective. This can then potentially be shared with the users own doctor who knows them best.”
Smit continued, “Moving into prevention with mymonX, our initial focus is to address the majority of people who want to know what their health vitals are and how to interpret them. We are also planning clinical trials for mymonX, like we did for our AI chronic wound diagnostics solution/app, but for now this is a lifestyle device. Our customer’s feedback is super important to us leading to new features and different types of wearables like armbands and clip-ons to be added in due course.”
The mymonX smart health wearable is now available for purchase on the mymonX website for £249 with full access to all the features of the mymonX app for £9.99/month.
AITIS was founded to provide risk assessment products and services using our deep-tech AI technology stack and experience. We deeply care about detection, diagnosis and prevention to save and improve lives.
Our AITIS deep-tech AI platform has been used to build models with AI model explainability in different verticals including healthcare, construction safety, financial services, air pollution monitoring and traffic management.
We are located in the UK, Singapore and the Netherlands and are looking to expand globally.